Pharmacokinetics: From ADME to PK/PD

This module likely covers the concept of concentration-time curves in pharmacokinetics. Students will learn how to interpret and analyze these curves, which show how drug concentrations in plasma change over time after administration.

This module probably explores the distribution of drugs in blood and plasma, focusing on the importance of plasma protein binding in drug pharmacokinetics. Students will learn how these factors affect drug concentration and efficacy.

This module likely introduces the fundamental concepts of ADME (Absorption, Distribution, Metabolism, Excretion) and their relationship to pharmacokinetics. Students will gain an understanding of how these processes influence a drug's behavior in the body.

This module probably covers the specific pharmacokinetic parameters associated with intravenous drug administration. Students will learn how to calculate and interpret PK parameters such as volume of distribution, clearance, and half-life for IV dosing.

This module likely focuses on the pharmacokinetic parameters specific to oral drug administration. Students will learn about bioavailability, absorption rate, and how these factors affect drug concentration profiles and dosing strategies for orally administered medications.

This module probably explores various alternative routes of drug administration beyond oral and intravenous. Students will learn about the pharmacokinetic considerations for routes such as transdermal, subcutaneous, intramuscular, and others, and how these affect drug absorption and distribution.

This module likely covers laboratory techniques used to assess drug solubility and permeability. Students will learn about various assays and their importance in predicting drug absorption and bioavailability.

This module probably focuses on laboratory methods used to evaluate the metabolic stability of drugs. Students will learn about in vitro assays that predict how quickly a drug is metabolized, which is crucial for understanding its in vivo behavior and half-life.

This module likely covers the design, execution, and interpretation of in vivo pharmacokinetic studies. Students will learn about animal models, study protocols, and how to extrapolate animal data to predict human pharmacokinetics.

This module probably delves into the specifics of drug metabolism in the liver. Students will learn about hepatic enzymes, first-pass metabolism, and how liver function affects drug pharmacokinetics and dosing strategies.

This module likely focuses on the processes of drug elimination through the kidneys and bile. Students will learn about renal clearance, glomerular filtration, tubular secretion, and biliary excretion, and how these affect drug half-life and dosing.

This module probably explores the unique pharmacokinetic considerations for biologic drugs such as proteins and antibodies. Students will learn how the PK properties of biologics differ from small molecule drugs and the implications for drug development and dosing.

This module likely covers the integration of pharmacokinetics and pharmacodynamics. Students will learn how to relate drug concentrations to therapeutic effects and use PK-PD modeling to optimize dosing regimens and predict drug efficacy.

This module probably focuses on methods for predicting appropriate human dosages based on preclinical and early clinical data. Students will learn about allometric scaling, physiologically-based pharmacokinetic (PBPK) modeling, and other techniques used to estimate human doses.

This module likely covers how drug formulation affects pharmacokinetics. Students will learn about different formulation strategies, controlled release technologies, and how formulation choices can optimize drug absorption, distribution, and overall PK profile.